Scientists have developed an "adapter plug" molecule that transforms spare antibodies into HIV killers, in what could be a major step in the fight against AIDS.
In this novel way to treat AIDS and other viruses, the molecule targets the antibodies, called anti-gal, which are naturally present in humans and constitute 1 percent of all antibodies in the blood.
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with precautions. AIDS/HIV symptoms manifest long after the actual infection occurs.
Advertisement
The anti-gals help to fight Salmonella and Escherichia coli by binding to a sugar on the bacteria's surfaces. However, they fail when it comes to fighting a serious infection.
"Most of the time these antibodies don't do much, so we thought it would be useful if we could teach them to recognise HIV," the New Scientist quoted Anders Vahlne at the Karolinska Institute in Stockholm, Sweden, as saying.
![Female Condom - Animation]( "Female Condom - Animation")
The researchers created a molecule with one end having the sugar group recognised by anti-gal. And on the other hand, they attached a string of atoms that imitates part of a receptor, found on human immune cells, that binds to HIV.
The resultant molecule binds to anti-gal and HIV, and behaves like a kind of adapter plug for the antibodies, enabling their inherent cell-destroying machinery to kill HIV-infected cells.
"The antibodies block the interaction between virus and host cell, recruit molecules that will destroy infected cells, and alert killer cells that will eat them," said Vahlne.
The researchers added HIV viruses to human cells that had been primed with the adapter molecules and anti-gal antibodies and found that nearly 90 percent of the viruses failed to infect the cells.
While there was a need to test the adapters in HIV-infected mice, Rowena Johnston of AIDS research foundation amfAR said that the work demonstrates how "we might be able to use the innate immune system in a surprising and intriguing way."
Source: ANI
RAS/S
Advertisement
The researchers created a molecule with one end having the sugar group recognised by anti-gal. And on the other hand, they attached a string of atoms that imitates part of a receptor, found on human immune cells, that binds to HIV.
The resultant molecule binds to anti-gal and HIV, and behaves like a kind of adapter plug for the antibodies, enabling their inherent cell-destroying machinery to kill HIV-infected cells.
"The antibodies block the interaction between virus and host cell, recruit molecules that will destroy infected cells, and alert killer cells that will eat them," said Vahlne.
The researchers added HIV viruses to human cells that had been primed with the adapter molecules and anti-gal antibodies and found that nearly 90 percent of the viruses failed to infect the cells.
While there was a need to test the adapters in HIV-infected mice, Rowena Johnston of AIDS research foundation amfAR said that the work demonstrates how "we might be able to use the innate immune system in a surprising and intriguing way."
Source: ANI
RAS/S
How to use a condom - Animation
This Interactive provides step by step visual aid showing how to correctly use condoms which can prevent transmission of HIV, other sexually transmitted diseases and pregnancy
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest AIDS/HIV News
A new study has found that the co-localization of tuberculosis disease and HIV in lymphatic tissues leads to the emergence of potent HIV antibodies.
Specific antiviral drug that is widely used to treat smallpox patients since last summer's outbreak is found to produce similar outcomes regardless of the patient's HIV status.
In susceptible communities because of poverty, and racism, the effects of inadequate STI and HIV screening may be more profound.
In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.
Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.